Anna Meyfour

TGF-β receptor I inhibitor may restrict the induction of EMT in inflamed intestinal epithelial cells

Mahsa Ghorbaninejad, Meghdad Abdollahpour‐Alitappeh, Shabnam Shahrokh et al. · Experimental Biology and Medicine · 2023 · 15 citations · Full text

Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease

Raheleh Heydari, Padideh Karimi, Anna Meyfour · Biomedicine & Pharmacotherapy · 2024 · 15 citations · Full text

Pasteurized form of a potential probiotic lactobacillus brevis IBRC-M10790 exerts anti-inflammatory effects on inflammatory bowel disease in vitro

Ardeshir Ebrahiminejad, Abbas Akhavan Sepahi, Abbas Yadegar et al. · BMC Complementary Medicine and Therapies · 2024 · 15 citations · Full text

Inhibition of epithelial SHH signaling exerts a dual protective effect against inflammation and epithelial–mesenchymal transition in inflammatory bowel disease

Mahsa Ghorbaninejad, Anna Meyfour, Samaneh Maleknia et al. · Toxicology in Vitro · 2022 · 13 citations

Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells

Mahsa Ghorbaninejad, Maliheh Khademi-Shirvan, Samaneh Hosseini et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2022 · 12 citations